1. Introduction: Lynch syndrome—its molecular mechanism and current topics

   • Naohiro Tomita

   Introduction to Invited Review Articles 09 May 2018 Pages: 997 - 998

2. Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome

   • Kazuo Tamura
   • Motohide Kaneda
   • Junko Tatsumi-Miyajima

   Invited Review Article 04 July 2019 Pages: 999 - 1011

   

3. Correction to: Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome

   • Kazuo Tamura
   • Motohide Kaneda
   • Junko Tatsumi-Miyajima

   Correction 31 July 2019 Pages: 1012 - 1012

   

4. Current clinical topics of Lynch syndrome

   • Kohji Tanakaya

   Invited Review Article 09 May 2018 Pages: 1013 - 1019

5. Cell-type-specific sensitivity of bortezomib in the methotrexate-resistant primary central nervous system lymphoma cells

   • Azusa Hayano
   • Yasuo Takashima
   • Ryuya Yamanaka

   Original Article 16 April 2019 Pages: 1020 - 1029

   

6. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis

   • Ke Yang
   • Shizhou Zhang
   • Tengda Zhao

   Original Article Open access 01 April 2019 Pages: 1030 - 1041

   

7. Association of SNPs in the OBFC1 gene and laryngeal carcinoma in Chinese Han male population

   • Peng Han
   • Zhongping Dang
   • Yuan Shao

   Original Article 23 April 2019 Pages: 1042 - 1048

   

8. Establishment and validation of a novel survival prediction scoring algorithm for patients with non-small-cell lung cancer spinal metastasis

   • Shizhao Zang
   • Qin He
   • Weibin Zhang

   Original Article 26 April 2019 Pages: 1049 - 1060

   

9. Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas

   • Xiaohong Liang
   • Qing Li
   • Chong Li

   Original Article 07 May 2019 Pages: 1061 - 1068

   

10. Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients

    • Kimiharu Takamatsu
    • Ryuichi Mizuno
    • Mototsugu Oya

    Original Article 07 May 2019 Pages: 1069 - 1074

    

11. High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma

    • Gaku Yamamichi
    • Wataru Nakata
    • Masao Tsujihata

    Original Article 11 April 2019 Pages: 1075 - 1080

    

12. Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort

    • Katsuhiro Ito
    • Toru Kanno
    • Osamu Ogawa

    Original Article 10 April 2019 Pages: 1081 - 1088

    

13. Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses

    • Chikara Ohyama
    • Takahiro Kojima
    • Go Kimura

    Original Article 19 June 2019 Pages: 1089 - 1098

    

14. Predictive factors for short-term biochemical recurrence-free survival after robot-assisted laparoscopic radical prostatectomy in high-risk prostate cancer patients

    • Mitsugu Kanehira
    • Ryo Takata
    • Wataru Obara

    Original Article 10 April 2019 Pages: 1099 - 1104

    

15. Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan

    • Hidetaka Nomura
    • Masayuki Sekine
    • Seigo Nakamura

    Original Article 04 May 2019 Pages: 1105 - 1110

    

16. Feasibility of initial treatment in elderly patients with ovarian cancer in Japan: a retrospective study

    • Seiko Bun
    • Mayu Yunokawa
    • Kenji Tamura

    Original Article 15 April 2019 Pages: 1111 - 1118

    

17. Tumor growth patterns on magnetic resonance imaging and treatment outcomes in patients with locally advanced cervical cancer treated with definitive radiotherapy

    • Shintaro Tsuruoka
    • Masaaki Kataoka
    • Teruhito Mochizuki

    Original Article 11 May 2019 Pages: 1119 - 1128

    

18. Does the extension of the type of hysterectomy contribute to the local control of endometrial cancer?

    • Tetsuya Hasegawa
    • Megumi Furugori
    • Yokohama City University Gynecologic Oncology Research Group (YCUGO-ReG)

    Original Article Open access 08 May 2019 Pages: 1129 - 1136

    

19. Trends in incidence and long-term survival of Japanese women with vulvar cancer: a population-based analysis

    • Yusuke Tanaka
    • Yutaka Ueda
    • Tadashi Kimura

    Original Article 25 April 2019 Pages: 1137 - 1142

    

20. Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS)

    • Noriyuki Okonogi
    • Takuya Kaminuma
    • Tadashi Kamada

    Original Article Open access 09 April 2019 Pages: 1143 - 1150

    

21. Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis

    • Chen XiaoHong
    • Shen Bo
    • Zhang Boheng

    Original Article 10 June 2019 Pages: 1151 - 1160

    

22. Current status of site-specific cancer registry system for the clinical researches: aiming for future contribution by the assessment of present medical care

    • Koichi Hirata
    • Masafumi Imamura
    • Masahiko Nishiyama

    Original Article 22 April 2019 Pages: 1161 - 1168

    

23. Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib

    • Kazuo Tamura
    • Toshihiro Nukiwa
    • Yoichi Nakanishi

    Correction Open access 25 June 2019 Pages: 1169 - 1169